Trang chủ » blog » Malignant Peritoneal Mesothelioma | Causes, Treatment, and Prognosis

Malignant Peritoneal Mesothelioma | Causes, Treatment, and Prognosis

What Is Malignant Peritoneal Mesothelioma?

Peritoneal mesothelioma is a cancer of the peritoneum. It is besides known as peritoneal cancer. The peritoneum is a thin membrane that creates the line of the abdominal pit, arising from mesothelial cells. It consists of two thin layers called the intuitive peritoneum and the parietal peritoneum .

Facts About Peritoneal Mesothelioma

Because this cancer is indeed rare, most people don ’ t know much about it. Here are some quick facts about peritoneal mesothelioma:

  • All types of mesothelioma are aggressive and spread rapidly.
  • Known asbestos exopsure occurs in only about half of all cases of peritoneal mesothelioma.
  • Women, especially those without past asbestos exposure, account for most cases of multicystic and well-differentiated peritoneal mesothelioma. These types have long survival times.
  • Mesothelioma is rare, accounting for about 3,000 cases of cancer per year. Of those only 200 to 400 are peritoneal mesothelioma.
  • The highest numbers of diagnoses occur in people between the ages of 50 and 69.
  • Between 2% and 5% of peritoneal mesothelioma cases occur in people aged 20 or younger.
  • Survival time is often longer for peritoneal mesothelioma than pleural mesothelioma.

What Causes This Type of Mesothelioma?

patient doctor looking at tablet The main cause of any type of mesothelioma is asbestos exposure. The longer and more patronize the exposure, the greater the gamble of developing mesothelioma.

Experts believe other risk factors, like genetics and family history, also play a role because not everyone exposed to asbestos develops cancer. besides, some patients with peritoneal mesothelioma have no know history of asbestos exposure. Prolonged asbestos exposure is most much associated with pleural mesothelioma because exposure is normally through inhalation of the fibers, but it can besides trigger the peritoneal form in the abdomen. There are two possible ways that asbestos fibers may travel to the abdominal cavity and cause peritoneal cancer:

  • Asbestos fibers may also be ingested and may be present in the sputum. Over time, these fibers reach the peritoneal surface by penetrating the wall of the intestine. This process can ultimately lead to the development of cancerous cells.
  • Fibers that have been inhaled may also migrate through the lymphatic system and end up in the abdomen where they cause damage.

How Peritoneal Mesothelioma Develops

Whether they get there through inhalation or consumption, asbestos fibers in the abdomen become embedded in the peritoneum cells. There they trigger inflammation and damage. cellular wrong can lead to those cells becoming cancerous, growing, and dividing out of control. They then develop into tumors that may spread further through the peritoneum and to other tissues and organs .

What if I Was Never Exposed to Asbestos?

peritoneal differs from the pleural form of mesothelioma in that more patients report no exposure to asbestos. Asbestos causes cancer typically by inhalant of the fibers, which is why pleural mesothelioma is more common. Approximately half of all people diagnosed with the peritoneal form have no known past asbestos exposure. There may be several explanations for this :

  • They did encounter asbestos in the past but didn’t realize it.
  • They experienced asbestos exposure second-hand, for instance, by living with someone who works around asbestos and unintentionally brings fibers home on clothing or in hair.
  • There may be other causes of mesothelioma, such as genetics, radiation exposure, or exposure to a virus known as SV40.

If you have symptoms of peritoneal mesothelioma but no know exposure, doctors will eliminate other, more likely causes first .

Why Are Women More Likely to Get Peritoneal Mesothelioma?

The majority of cases of both pleural and peritoneal mesothelioma are in men. however, more women receive diagnoses of peritoneal than pleural mesothelioma. world are at greater risk because of their preponderance in workplaces that used asbestos. Young women, in finical, make up most cases of multicystic and well-differentiated peritoneal mesothelioma. Experts don ’ t know why, but they suspect fibromatosis, a benight growth that affects women, may be a contribute factor. The well newsworthiness for women with these types of peritoneal mesothelioma is that they are not aggressive and rarely metastasize. Surgery is much curative .

What Are the Symptoms of Peritoneal Mesothelioma?

Icon of Abdomen The symptoms of peritoneal mesothelioma may not be obvious, or they may be mild and not show until many years, even decades, after asbestos exposure. Significant and harmful delays in diagnosis much occur for this argue. Peritoneal mesothelioma may cause :

  • Ascites, fluid build up and swelling in the abdomen
  • Abdominal pain
  • Unintentional and unexplained weight loss
  • Diarrhea
  • Constipation
  • Bowel obstruction
  • Anemia
  • Fever
  • Fatigue
  • Nausea
  • Vomiting

How Is Peritoneal Mesothelioma Diagnosed?

The early symptoms of peritoneal mesothelioma make it challenging to diagnose. They are alike to symptoms of cranky intestine syndrome, Crohn ’ s disease, colitis, and other more common gastrointestinal disorders. Doctors are more probably to diagnose these inaugural, leading to a misdiagnosis. This is specially likely if they are unaware of any asbestos exposure a patient may have experienced. The first step in getting an accurate diagnosis is a physical exam and a thorough history. Tell your healthcare supplier if you have or think you may have experienced asbestos exposure. These steps will follow a forcible examination in most cases :

  • After reviewing your symptoms and performing a physical exam, your doctor may start ordering imaging studies, usually beginning with a simple X-ray or CT scan. These studies can help identify peritoneal changes, such as thickening of the lining, or a tumor mass to suggest the presence of cancer. Other specialized imaging such as MRI or PET/CT scans are usually ordered by specialty providers and may take place after a biopsy.
  • A blood test may also be used to determine if you have any tumor markers, any substances that are associated with cancer.
  • If there are visible abnormalities on a scan, a biopsy is used to determine a diagnosis. This is usually done by an interventional radiologist, a specialist trained in both reading imaging scans and performing minimally invasive biopsies. Most biopsies can be performed at a local hospital with patients going home the same day.
  • In some cases, a more invasive surgical biopsy may be necessary. This happens when the tissue in question is difficult to reach or the routine biopsy could not gather enough cells to give your medical team a firm diagnosis.

At this point, a surgeon will usually recommend a laparoscopy in the operating room under general anesthesia. This allows the surgeon to use a television camera to look inside the abdominal cavity looking for any signs of cancer, and choose the best location to biopsy. Laparoscopy is an excellent instrument by which the surgeon can directly visualize tumors within the abdomen and pelvis and also facilitate a biopsy of a cancerous nodule. however, it has been associated with mesothelioma growing out of the insertion site for the telescope. This is referred to as port locate metastases. In order to avoid this very dangerous dissemination of mesothelioma to the abdominal wall, laparoscopy for mesothelioma must only be performed through the absolute midplane of the abdomen. normally, the telescopy is placed just above or below the navel. If cancer grows out at a midplane larboard site, it can be excised without excessive damage to the muscles, nerves, and fascia that make up the abdominal wall .

Staging Peritoneal Mesothelioma

Staging cancer is authoritative for giving patients an calculate prognosis or life anticipation and for informing discussion. Due to its rarity, peritoneal mesothelioma has no official spy system. many doctors rely on the TNM system used for pleural mesothelioma to designate a stage :

  • Stage I. Tumors are only in the peritoneum and are limited.
  • Stage II. By stage II, tumors have grown and spread but have still not invaded the lymph nodes.
  • Stage III. When tumors spread outside the peritoneum or invade the lymph nodes, the stage is often labeled as III.

Some doctors include a fourth stage, which describes metastatic cancer .

Can Peritoneal Mesothelioma Be Misdiagnosed?

Peritoneal mesothelioma is extremely rare, and most doctors–even oncologists–have no experience with it. The symptoms can be undefined and exchangeable to other illnesses, and many people don ’ t have past vulnerability to asbestos as a hint. For all these reasons, misdiagnosis is common. Typical misdiagnoses include hernia, cranky intestine syndrome, Crohn ’ second disease and colitis, ovarian cysts or cancer, and other types of abdominal cancer. It ’ sulfur essential that you seek a second opinion if you don ’ triiodothyronine feel good about a diagnosis you receive. If doctors have ruled out more coarse illnesses, see an oncologist or mesothelioma specialist .

How Is Peritoneal Mesothelioma Treated?

patient chemotherapy Treatment options for peritoneal mesothelioma include the standard therapies of surgery; chemotherapy; radiation is rarely indicated. There are, as good, some new and experimental therapies. Oncologists, specially those who specifically work with mesothelioma patients, are well suited to plan your treatments. They will most likely recommend a combination of therapies based on your cancer’s stage, your health and age, and your preferences.

Cytoreductive Surgery and HIPEC

A new, advanced discussion has been used with more success in patients with peritoneal mesothelioma and is now the standard therapy. It is called cytoreductive operating room plus HIPEC, or heated intraperitoneal chemotherapy :

  • Cytoreductive surgery. The first step in this procedure is a radical surgery to remove as much cancerous tissue as possible. Completer removal gives the best results.
  • Heated chemotherapy. Then heated chemotherapy drugs are administered directly into the abdomen at the end of surgery.


Some patients are not adept candidates for operation and may benefit from systemic chemotherapy. A typical first-line discussion combination is pemetrexed with cisplatin or carboplatin. Although not angstrom effective as operating room with HIPEC, systemic chemotherapy extends animation anticipation for patients with peritoneal mesothelioma .

Advances in Immunotherapy

Researchers at MD Anderson Cancer Center recently reported positive results in clinical trials using immunotherapy drugs for peritoneal mesothelioma patients. These medications enhance the immune system in respective ways to help target cancer cell death. In a phase II clinical test, the research worker got a positive reply in 40 % of participants. It extended survival clock in these patients. The discussion besides proved safe. This trial used the combination of atezolizumab and bevacizumab .

Can Peritoneal Mesothelioma Be Cured?

All cases of mesothelioma are considered incurable, but some patients survive for many years and may be considered cured. This consequence is more likely in peritoneal than pleural mesothelioma. One cause is that peritoneal mesothelioma spreads less aggressively. It besides responds well to the fresh HIPEC treatment after cytoreductive operation, a discussion not however found to be beneficial to pleural patients.

Who Are the Leading Peritoneal Mesothelioma Doctors?

Paul Sugarbaker, M.D.

Dr. Paul Sugarbaker is one of the world ’ south leading experts on peritoneal mesothelioma. He besides specializes in treating cancers that have metastasized to the peritoneum. He is the Chief of the Peritoneal Surface Malignancy Program at Washington, D.C. ’ s Washington Hospital Center. He is besides the Director of the Center for Gastrointestinal Malignancies. During his career, Dr. Sugarbaker has worked both in clinical practice and research, including a decade as a Senior Investigator at the National Cancer Institute. He pioneered a discussion scheme for peritoneal mesothelioma, now known as the Sugarbaker Procedure. It involves using cytoreductive surgery followed by circulating heated chemotherapy drugs ( HIPEC ) throughout the abdominal pit. The procedure is now used wide and has helped extend the life anticipation of many peritoneal cancer patients .Paul Sugarbaker, M.D.

Kiran Turaga, M.D.

Dr. Kiran Turaga is a surgical oncologist with a special interest in treating progress malignancies, including metastatic cancers ( cancers that have spread beyond their original web site to other parts of the body ). Dr. Turaga has published widely on peritoneal mesothelioma. He is the Professor of Surgical Oncology at the University of Chicago. He recently constructed a working group to provide multidisciplinary recommendations for the discussion of peritoneal mesothelioma. His guidelines were developed with remark from leading experts, including surgical oncologists, medical oncologists, pathologists, radiologists, alleviative worry physicians, and pharmacists. His exploit has increased awareness of this disease and provided allow management strategies for malignant peritoneal mesothelioma. Dr. Turaga is an technical in regional perfusion, including hyperthermic intraperitoneal chemotherapy ( HIPEC ), a proficiency that delivers high doses of inflame chemotherapy immediately to abdominal organs to kill cancer cells that may remain after surgical removal of visible tumors. He is highly skilled in minimally encroaching approaches, including robotic operating room. He uses these innovative techniques to surgically treat and remove dangerous cancers with smaller incisions and shorter convalescence times. Dr. Turaga is an avid and influential research worker who has published over 100 peer-reviewed articles and is an external authority on peritoneal open disease. His clinical research focuses on the development of novel diagnostics and therapeutics for oligo-metastatic cancer. He is besides matter to in studying how big data systems can provide the most optimum, cost-efficient patient care .Kiran Turaga, M.D.

Andrew Blakely, M.D.

Dr. Andrew Blakely is a surgical oncologist specializing in peritoneal airfoil and retroperitoneal malignancies. A basal focus of his research is to develop fresh treatment approaches and modalities to improve pre-operative treatment of peritoneal carcinomatosis. presently, Dr. Blakely is a aged detective at the Surgery Branch, National Cancer Institute in Bethesda, Maryland. He is the surgeon designated to work with the multidisciplinary team at the National Institutes of Health on clinical and inquiry studies in malignant peritoneal mesothelioma. Protocols for managing peritoneal mesothelioma are open at the National Institutes of Health and promise to bring fresh information to bear on this rare disease .Andrew Blakely, M.D.

David Bartlett, M.D.

Dr. David Bartlett is presently Professor of Surgery and Director of the Surgical Oncology Program at the Allegheny Medical and Surgical Network. He has extensive experience treating peritoneal mesothelioma that began two decades ago at the National Institutes of Health. He has published his data on the management of peritoneal mesothelioma wide in the peer-reviewed literature and is presently engaged in clinical and experimental research with this disease. Dr. Bartlett served as a Senior Investigator at the Surgery Division of the Center for Cancer Research at the National Cancer Institute, where he developed innovative surgical techniques to treat patients with peritoneal metastases. He is presently President of the Society of Surgical Oncology .David Bartlett, M.D.

What Are the Best Treatment Centers for Peritoneal Mesothelioma?

To get the best consequence for this rare disease, you need specialist discussion. not many oncologists or surgeons specialize in peritoneal mesothelioma. You may need to travel to one of these celebrated cancer centers for the best treatment options :

How Long Can I Live with Peritoneal Mesothelioma?

The prognosis for peritoneal mesothelioma is generally poor given the aggressive nature of the disease. however, it is normally much better than the mentality for pleural mesothelioma. overall prognosis improves if you are a candidate for cytoreductive surgery plus HIPEC. Several factors determine each patient’s prognosis:

  • Age and health
  • Gender
  • Stage of the cancer at diagnosis
  • Treatments chosen
  • Concerning radiological features on CT identified by an experienced radiologist.

For peritoneal mesothelioma, the median survival time without disease progression–that is, the time a patient lives from diagnosis with no far worsening of the disease–is just 13.9 months. By stage, the five-year survival rates for peritoneal mesothelioma are :

  • Stage I – 87%
  • Stage II – 53%
  • Stage III – 29%

How to Improve Prognosis

The best chance you have of a good prognosis for peritoneal mesothelioma is with an early diagnosis. Finding out about it in the early on stages gives you more treatment options. Aggressive, early treatments can increase the total of fourth dimension patients spend without visible cancer and allow patients to feel good long. It is important to discuss the potential risks and complications with your aesculapian caution team to ensure you make the right decision. Choosing a team that has feel with mesothelioma can be very helpful. The best survival rates are seen with patients who undergo cytoreductive surgery plus HIPEC. A 2017 study involved twenty-nine mesothelioma patients who received surgery followed by heat chemotherapy. about three-quarters of the patients lived longer than five years after treatment, a adult improvement in overall survival times. Getting a diagnosis for peritoneal mesothelioma may be devastating, but you have options and hope. You may get a second opinion and then seek treatment at a Peritoneal Surface Oncology center. You can choose from aggressive treatments and those that will make you feel more comfortable in the clock you have left. You may besides be able to file a lawsuit to seek recompense if you were exposed to asbestos in the workplace .

Frequently Asked Questions

What Causes Peritoneal Mesothelioma ? The leading campaign of any type of mesothelioma is asbestos exposure. consume fibers of asbestos cause pique and damage that may lead to tumor emergence in the peritoneum. not everyone exposed to the mineral will develop cancer. other risk factors involved include syndicate history and genetics and radiation therapy to the abdomen. What Are the Symptoms of Peritoneal Mesothelioma ? The common symptoms of peritoneal mesothelioma are abdominal swell and distention from ascites and abdominal pain. other symptoms include nausea, a feel of comprehensiveness, and unintended weight personnel casualty. Rare symptoms may include hernia, fever, and night sweats. How long Can You Live with Peritoneal Mesothelioma ? survival time varies based on cancer degree, affected role health and age, and treatment chosen. Life anticipation is broadly longer than for pleural mesothelioma. If treatments are not available to you, survival may be less than a class. Survival pace for peritoneal mesothelioma after one year is 50 %, after two years 35 %, and after five years, good 18 %. Is Peritoneal Mesothelioma Curable ? Most cases of mesothelioma are considered incurable, but often accomplishable. Patients with the best hope of being cured of peritoneal mesothelioma receive a diagnosis in an early stage, are younger and in good health, and are able to undergo aggressive treatment. flush with remission, the cancer may return late. How Quickly Does Peritoneal Mesothelioma Spread ? The first gear survival rates for mesothelioma indicate how quickly it spreads. This is an aggressive type of cancer that metastasizes readily within the peritoneal cavity. How debauched it spreads depends on the cellular telephone type. In one analyze, patients with the epithelioid type of peritoneal mesothelioma had a median survival time of fifty-five months, while those with a biphasic type saw a median survival time of precisely thirteen months.

Page Medically Reviewed and Edited by Paul Sugarbaker, M.D.

Paul Sugarbaker, M.D. Dr. Paul Sugarbaker is a leading technical in surgical oncology. He specializes in the surgical treatment of gastrointestinal cancers, peritoneal mesothelioma, and peritoneal metastases. He developed and advanced an crucial discussion routine for peritoneal cancers and metastases known as HIPEC. The innovative strategy uses operating room followed by the circulation of heat chemotherapy drugs in the abdomen. Dr. Sugarbaker presently heads up the Peritoneal Surface Malignancy Program and the Center for Gastrointestinal Malignancies at Washington Hospital Center. He besides works out of a private rehearse, Sugarbaker Oncology Associates .Connect with Mesothelioma Doctor Paul Sugarbaker, M.D. References

  1. Bridda, A., Padoan, I., Mencarelli, R. and Frego, M. (2007, May 10). Peritoneal Mesothelioma: A Review. MedGenMed. 9(2), 32.
    Retrieved from:
  2. Kalra, A. and Tuma, F. (2018, November 26). Anatomy, Abdomen, and Pelvis, Peritoneum. StatPearls.
    Retrieved from:
  3. Kanarek, M.S. and Mandich, M.K. (2016, March 29). Peritoneal Mesothelioma and Asbestos: Clarifying the Relationship by Epidemiology. Epidemiology. doi:10.4172/2161-1165.1000233.
    Retrieved from:
  4. The American Cancer Society. (2018, November 16). What Causes Malignant Mesothelioma?
    Retrieved from:
  5. American Cancer Society. (2018, November 16). Signs and Symptoms of Mesothelioma.
    Retrieved from:
  6. Sugarbaker, P.H, Turaga, K.K., Alexander, H.R., Deraco, M. & Hesdorffer, M. (2016). Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. Journal of Oncology Practice, 12(10), 928-35.
    Retrieved from:
  7. Kim, J., Bhagwandin, S. & Labow, D.M. (2017). Malignant Peritoneal Mesothelioma: A Review. Annals of Translational Medicine, 5(11), 236.
    Retrieved from:
  8. Lemoine, L., Sugarbaker, P., and Van der Speeten, K. (2017). Drugs, Doses, and Durations of Intraperitoneal Chemotherapy: Standardising HIPEC and EPIC for Colorectal, Appendiceal, Gastric, Ovarian Peritoneal Surface Malignancies and Peritoneal Mesothelioma. International Journal of Hypothermia. 33(5), 582-92.
    Retrieved from:
  9. MD Anderson Cancer Center. (2021, July 14). Atezolizumab and Bevacizumab Show Meaningful Responses for Malignant Peritoneal Mesothelioma Patients.
    Retrieved from:
  10. Magge, D., Zenati, M.S., Austin, F., Mavanur, A., Sathaiah, M., Ramalingam, L., Jones, H., Zureikat, A.H., Holtzman, M., Ahrendt, S., Pingpank, J., Zeh, H.J., Bartlett, D.L. and Choudry, H.A. (2014, April). Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis. Ann. Surg. Oncol. 21(4), 1159-65.
    Retrieved from:

View All References

source :
Category : Healthy

Post navigation

Leave a Comment

Trả lời

Email của bạn sẽ không được hiển thị công khai.